|
JPS509164A
(https=)
|
1973-05-11 |
1975-01-30 |
|
|
|
AU576322B2
(en)
|
1983-07-22 |
1988-08-25 |
Ici Australia Limited |
Alpha-substituted-alpha-cyanomethyl alcohols
|
|
US4783443A
(en)
|
1986-03-03 |
1988-11-08 |
The University Of Chicago |
Amino acyl cephalosporin derivatives
|
|
JPS6411523A
(en)
|
1987-07-06 |
1989-01-17 |
Kawashima Tekko Kk |
Dish feeder in tableware washing machine
|
|
JPH059164A
(ja)
|
1991-07-02 |
1993-01-19 |
Sumitomo Chem Co Ltd |
光学活性マンデロニトリル誘導体の製造方法
|
|
GB9217331D0
(en)
|
1992-08-14 |
1992-09-30 |
Xenova Ltd |
Pharmaceutical compounds
|
|
AU5612694A
(en)
|
1992-11-27 |
1994-06-22 |
Napro Biotherapeutics, Inc. |
Injectable composition
|
|
JPH0725858A
(ja)
|
1993-07-13 |
1995-01-27 |
Otsuka Pharmaceut Co Ltd |
ピペラジン誘導体
|
|
GB9402807D0
(en)
|
1994-02-14 |
1994-04-06 |
Xenova Ltd |
Pharmaceutical compounds
|
|
GB9402809D0
(en)
|
1994-02-14 |
1994-04-06 |
Xenova Ltd |
Pharmaceutical compounds
|
|
GB9426224D0
(en)
|
1994-12-23 |
1995-02-22 |
Xenova Ltd |
Pharmaceutical compounds
|
|
US5891877A
(en)
|
1995-02-14 |
1999-04-06 |
Xenova Limited |
Pharmaceutical compounds
|
|
US5874443A
(en)
|
1995-10-19 |
1999-02-23 |
Trega Biosciences, Inc. |
Isoquinoline derivatives and isoquinoline combinatorial libraries
|
|
US5886210A
(en)
|
1996-08-22 |
1999-03-23 |
Rohm And Haas Company |
Method for preparing aromatic compounds
|
|
JP3131574B2
(ja)
|
1996-09-04 |
2001-02-05 |
新日本製鐵株式会社 |
新規抗腫瘍物質、該物質を製造するための微生物及び方法、並びに該物質を有効成分とする細胞周期阻害剤及び抗腫瘍剤
|
|
US5939098A
(en)
*
|
1996-09-19 |
1999-08-17 |
Schering Corporation |
Cancer treatment with temozolomide
|
|
US5922683A
(en)
|
1997-05-29 |
1999-07-13 |
Abbott Laboratories |
Multicyclic erythromycin derivatives
|
|
EP1032377B1
(en)
|
1997-11-21 |
2010-11-17 |
Purdue Neuroscience Company |
Substituted 2-aminoacetamides and the use thereof
|
|
DE69940191D1
(de)
|
1998-01-29 |
2009-02-12 |
Aventis Pharma Inc |
VERFAHREN ZUR HERSTELLUNG EINER N-i(ALIPHATHISCH ODER AROMATISCH)CARBONYL -2-AMINOACETAMID-VERBINDUNG UND EINER CYCLISCHEN VERBINDUNG
|
|
US7141603B2
(en)
|
1999-02-19 |
2006-11-28 |
The Regents Of The University California |
Antitumor agents
|
|
US6069146A
(en)
|
1998-03-25 |
2000-05-30 |
The Regents Of The University Of California |
Halimide, a cytotoxic marine natural product, and derivatives thereof
|
|
BR9909146A
(pt)
|
1998-03-26 |
2000-12-05 |
Shionogi & Co |
Derivados de indol apresentando uma atividade antiviral
|
|
US6509331B1
(en)
|
1998-06-22 |
2003-01-21 |
Elan Pharmaceuticals, Inc. |
Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
FR2784988B1
(fr)
|
1998-10-23 |
2002-09-20 |
Adir |
Nouveaux composes dihydro et tetrahydroquinoleiniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US7026322B2
(en)
|
1998-11-12 |
2006-04-11 |
Nereus Pharmaceuticals, Inc. |
Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
|
|
US6358957B1
(en)
|
1998-11-12 |
2002-03-19 |
Nereus Pharmaceuticals, Inc. |
Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
|
|
JP5004390B2
(ja)
|
1999-08-23 |
2012-08-22 |
デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド |
新規ｂ７−４分子およびその用途
|
|
PL354286A1
(en)
|
1999-08-23 |
2003-12-29 |
Dana-Farber Cancer Institutedana-Farber Cancer Institute |
Pd-1, a receptor for b7-4, and uses therefor
|
|
DK1234031T3
(en)
|
1999-11-30 |
2017-07-03 |
Mayo Foundation |
B7-H1, AN UNKNOWN IMMUNE REGULATORY MOLECULE
|
|
KR100831400B1
(ko)
|
2000-01-18 |
2008-05-21 |
니리어스 파마슈티컬즈, 인크. |
세포분열 저해제 및 그의 제조방법
|
|
BR0110745A
(pt)
|
2000-05-09 |
2003-12-30 |
Adpharma Inc |
Compostos de piperazinadiona
|
|
WO2002064592A1
(en)
|
2000-12-28 |
2002-08-22 |
Neurocrine Biosciences, Inc. |
Tricyclic crf receptor antagonists
|
|
US7012100B1
(en)
|
2002-06-04 |
2006-03-14 |
Avolix Pharmaceuticals, Inc. |
Cell migration inhibiting compositions and methods and compositions for treating cancer
|
|
US7935704B2
(en)
|
2003-08-01 |
2011-05-03 |
Nereus Pharmaceuticals, Inc. |
Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
|
|
US7919497B2
(en)
|
2002-08-02 |
2011-04-05 |
Nereus Pharmaceuticals, Inc. |
Analogs of dehydrophenylahistins and their therapeutic use
|
|
ES2295695T3
(es)
|
2002-08-02 |
2008-04-16 |
Nereus Pharmaceuticals, Inc. |
Deshidrofenilahistinas y sus analogos y la sintesis de deshidrofenilahistinas y sus analogos.
|
|
CN101899114A
(zh)
|
2002-12-23 |
2010-12-01 |
惠氏公司 |
抗pd-1抗体及其用途
|
|
AU2005212399B2
(en)
|
2004-02-04 |
2011-09-22 |
Nereus Pharmaceuticals, Inc. |
Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
|
|
DE202004018940U1
(de)
|
2004-12-07 |
2006-04-13 |
Asf Verwaltungs Gmbh |
Druckverschluß, Druckverschlußband und wiederverschließbarer Beutel
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
PT1907424E
(pt)
|
2005-07-01 |
2015-10-09 |
Squibb & Sons Llc |
Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
|
|
BRPI0706540A2
(pt)
*
|
2006-01-18 |
2011-03-29 |
Merck Patent Gmbh |
terapia especìfica usando ligantes de integrina para tratar cáncer
|
|
US8129527B2
(en)
|
2006-11-03 |
2012-03-06 |
Nereus Pharmacuticals, Inc. |
Analogs of dehydrophenylahistins and their therapeutic use
|
|
JP2011509299A
(ja)
|
2008-01-08 |
2011-03-24 |
ブリストル−マイヤーズ スクイブ カンパニー |
増殖性疾患治療のための、抗ｃｔｌａ−４抗体とチューブリン調節剤との組み合わせ
|
|
EP2262837A4
(en)
|
2008-03-12 |
2011-04-06 |
Merck Sharp & Dohme |
PD-1 BINDING PROTEINS
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
WO2010114922A1
(en)
*
|
2009-03-31 |
2010-10-07 |
Agios Pharmaceuticals, Inc. |
Methods of treating cancer having an aberrant egfr or kras genotype
|
|
GB0907551D0
(en)
|
2009-05-01 |
2009-06-10 |
Univ Dundee |
Treatment or prophylaxis of proliferative conditions
|
|
PT2464218E
(pt)
*
|
2009-08-10 |
2015-09-16 |
Univ Texas |
Tratamento de metástases do cérebro com inibidores de recetores de endotelina, em combinação com um agente quimioterapêutico citotóxico
|
|
PL2504364T3
(pl)
|
2009-11-24 |
2017-12-29 |
Medimmune Limited |
Ukierunkowane środki wiążące przeciwko B7-H1
|
|
WO2011146382A1
(en)
|
2010-05-17 |
2011-11-24 |
Bristol-Myers Squibb Company |
Improved immunotherapeutic dosing regimens and combinations thereof
|
|
EP2576514A1
(en)
*
|
2010-06-04 |
2013-04-10 |
Exonhit Sa |
Substituted isoquinolines and their use as tubulin polymerization inhibitors
|
|
JP2012033526A
(ja)
|
2010-07-28 |
2012-02-16 |
Fuji Electric Co Ltd |
薄膜太陽電池およびその製造方法
|
|
WO2012035436A1
(en)
|
2010-09-15 |
2012-03-22 |
Tokyo University Of Pharmacy And Life Sciences |
Plinabulin prodrug analogs and therapeutic uses thereof
|
|
TWI386203B
(zh)
*
|
2011-01-07 |
2013-02-21 |
Univ China Medical |
治療腦癌或用以降低腦癌細胞對替莫唑胺之抗藥性之醫藥組合物及其應用
|
|
JP6072771B2
(ja)
|
2011-04-20 |
2017-02-01 |
メディミューン，エルエルシー |
Ｂ７−ｈ１およびｐｄ−１に結合する抗体およびその他の分子
|
|
AU2013204313C1
(en)
*
|
2012-06-01 |
2016-04-07 |
Bionomics Limited |
Combination Therapy
|
|
AU2014244083B2
(en)
|
2013-03-13 |
2018-09-27 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for modulating chemotherapeutic cytotoxicity
|
|
US10809323B2
(en)
*
|
2013-04-24 |
2020-10-20 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Magnetic resonance maps for analyzing tissue
|
|
CA2926771C
(en)
|
2013-10-11 |
2022-07-05 |
Beyondspring Pharmaceuticals, Inc. |
Cancer treatment with combination of plinabulin and taxane
|
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
|
CN117100753A
(zh)
|
2015-02-12 |
2023-11-24 |
大连万春布林医药有限公司 |
普那布林联合免疫检查点抑制剂的用途
|
|
AU2016229294B2
(en)
|
2015-03-06 |
2021-11-04 |
Beyondspring Pharmaceuticals, Inc. |
Method of treating cancer associated with a RAS mutation
|
|
SG11201707128TA
(en)
|
2015-03-06 |
2017-09-28 |
Beyondspring Pharmaceuticals Inc |
Method of treating a brain tumor
|
|
JP6969848B2
(ja)
|
2015-07-13 |
2021-11-24 |
ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド |
プリナブリン組成物
|
|
KR20180105685A
(ko)
|
2016-02-08 |
2018-09-28 |
비욘드스프링 파마수티컬스, 인코포레이티드. |
투카레솔 또는 이의 유사체를 함유하는 조성물
|
|
JP7025416B2
(ja)
|
2016-06-06 |
2022-02-24 |
ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド |
好中球減少症を低減させるための組成物および方法
|
|
WO2018129381A1
(en)
|
2017-01-06 |
2018-07-12 |
Beyondspring Pharmaceuticals, Inc. |
Tubulin binding compounds and therapeutic use thereof
|
|
BR112019015974A2
(pt)
|
2017-02-01 |
2020-03-31 |
Beyondspring Pharmaceuticals, Inc. |
Método para reduzir neutropenia
|
|
CA3056077A1
(en)
|
2017-03-13 |
2018-09-20 |
Beyondspring Pharmaceuticals, Inc. |
Compositions of plinabulin and use thereof
|